Screening for cervical cancer in the developing world

Best Practice and Research: Clinical Obstetrics and Gynaecology

Volumn 19, Issue 4 SPEC. ISS., 2005, Pages 517-529

  Cronje H S ^a  

^a UNIVERSITY OF THE FREE STATE   (South Africa)

Author keywords

Cancer; Cervix; Developing countries; Neoplasia; Screening

Indexed keywords

ACETIC ACID; HUMAN PAPILLOMA VIRUS 16 VACCINE; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS VACCINE;

CANCER CONTROL; CANCER INCIDENCE; CANCER PREVENTION; CANCER SCREENING; COLPOSCOPY; COST EFFECTIVENESS ANALYSIS; CRYOTHERAPY; DEVELOPING COUNTRY; DISEASE ASSOCIATION; DISEASE COURSE; EARLY DIAGNOSIS; ELECTROSURGERY; FEMALE; HEALTH CARE COST; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNITY; IMMUNOSTIMULATION; LOW LEVEL LASER THERAPY; LOWEST INCOME GROUP; MASS SCREENING; PAPANICOLAOU TEST; PRIORITY JOURNAL; REVIEW; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX BIOPSY; UTERINE CERVIX CANCER; VACCINATION;

EID: 24644496255     PISSN: 15216934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bpobgyn.2005.02.005     Document Type: Review

References (57)

1. K.O. Rogo J. Omany J.N. Onyango et al. Carcinoma of the cervix in the African setting Int J Gynecol Obstet 33 1990 249-255
2. E.L. Franco N.F. Schlecht & D. Saslow The epidemiology of cervical cancer Cancer J 9 2003 348-359
3. F. Sitas J. Madhoo & J. Wessie Incidence of histologically diagnosed cancer in South Africa, 1993-1995 National Cancer Registry 1998 South African Institute of Medical Research Johannesburg
4. H.S. Cronje Screening for cervical cancer in developing countries Int J Gynecol Obstet 84 2004 101-108
5. S.A. Cannistra & J.M. Niloff Cancer of the uterine cervix N Engl J Med 334 1996 1030-1038
6. H.S. Cronje M.D. Trumpelmann P.D. Divall et al. Cervical cytological services in the Orange Free State. Demographic characteristics S Afr Med J 76 1989 615-618
7. N. Kiviat Natural history of cervical neoplasia: Overview and update Am J Obstet Gynecol 175 1996 1099-1104
8. G.J. van Oortmarssen & J.D. Habbema Epidemiological evidence for age-dependent regression of pre-invasive cervical cancer Br J Cancer 64 1991 559-565
9. H.S. Cronje B.F. Cooreman E. Beyer et al. Screening for cervical neoplasia in a developing country utilizing cytology, cervicography and the acetic acid test Int J Gynecol Obstet 72 2001 151-157
10. H.S. Cronje G.P. Parham B.F. Cooreman et al. A comparison of four screening methods for cervical neoplasia in a developing country Am J Obstet Gynecol 188 2003 395-400
11. M.T. Fahey L. Irwig & P. Macaskill Meta-analysis of Pap test accuracy Am J Epidemiol 141 1995 680-689
12. D.C. McCrory D.B. Matchar L. Bastian et al. Evaluation of Cervical Cytology. Evidence Report/Technology Assessment no. 5 (Prepared by Duke University under Contract no. 290-97-0014). AHCPR Publication no. 99-E010 1999 Agency for Health Care Policy and Research Rockville, MD
13. K. Nanda D.C. McCrory E.R. Myers et al. Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review Ann Intern Med 132 2000 810-819
14. A.A. Renshaw Measuring sensitivity in gynecologic cytology: A review Cancer 96 2002 210-217
15. P. De Sutter M. Coibion M. Vosse et al. A multicentre study comparing cervicography and cytology in the detection of cervical intraepithelial neoplasia Br J Obstet Gynaecol 105 1998 613-620
16. P.S. Basu R. Sankaranarayanan R. Mandal et al. Calcutta cervical cancer early detection group. Visual inspection with acetic acid and cytology in the early detection of cervical neoplasia in Kolkata, India Int J Gynecol Cancer 13 2003 626-632
17. P.J. Aucamp Cytodiagnosis of cervical neoplastic lesions in perspective S Afr Med J 64 1983 251-252
18. J.S. Mandelblatt W.F. Lawrence L. Gaffikin et al. Costs and benefits of different strategies to screen for cervical cancer in less-developed countries J Natl Cancer Inst 94 2002 1469-1483
19. E. Laara N.E. Day & M. Hakama Trends in mortality from cervical cancer in the Nordic countries: Association with organised screening programmes Lancet 1 1987 1247-1249
20. J. Bradley L. Risi & L. Denny Widening the cervical cancer screening net in a South African township: Who are the underserved? Health Care Women Int 25 2004 227-241
21. K.D. Hatch & J.S. Berek Intraepithelial disease of the cervix, vagina and vulva In J.S. Berek (ed) Novak's Gynecology 13th edn 2002 Lippincott Williams & Wilkins Philadelphia 478-479
22. American College of Obstetricians and Gynecologists. ACOG committee opinion Routine cancer screening. Number 185, September (replaces no. 128, October 1993) Int J Gynecol Obstet 59 1997 157-161
23. WHO meeting Control of cancer of the cervix uteri Bull World Health Organ 64 1986 607-618
24. M.G. Miller H.Y. Sung G.F. Sawaya et al. Screening interval and risk of invasive squamous cell cervical cancer Obstet Gynecol 101 2003 29-37
25. M. Lartey G. Joubert & H.S. Cronje Knowledge, attitudes and practices of rural women in South Africa regarding the Pap smear Int J Gynecol Obstet 83 2003 315-316
26. P. Gichangi B. Estambale J. Bwayo et al. Knowledge and practice about cervical cancer and Pap smear testing among patients at Kenyatta National Hospital, Nairobi, Kenya Int J Gynecol Cancer 13 2003 827-833
27. F.D. Cirisano Management of pre-invasive disease of the cervix Semin Surg Oncol 16 1999 222-227
28. V. Singh A. Sehgal & U.K. Luthra Screening for cervical cancer by direct inspection BMJ 304 1992 534-535
29. A. Singer M. Coppleson K. Canfell et al. A real time optoelectronic device as an adjunct to the Pap smear for cervical screening: A multicenter evaluation Int J Gynecol Cancer 13 2003 804-811
30. A. Stafl Cervicography: A new method for cervical cancer detection Am J Obstet Gynecol 139 1981 815-825
31. D.L. Schneider L. Burke T.C. Wright et al. Can cervicography be improved? An evaluation with arbitrated cervicography interpretations Am J Obstet Gynecol 187 2002 15-23
32. M. Ottaviano & P. La Torre Examination of the cervix with the naked eye using acetic acid test Am J Obstet Gynecol 143 1982 139-142
33. L. Gaffikin M. Lauterbach & P.D. Blumenthal Performance of visual inspection with acetic acid for cervical cancer screening: A qualitative summary of evidence to date Obstet Gynecol Surv 58 2003 543-550
34. C.A. Ngelangel G.M. Limson C.P. Cordero et al. Acetic-acid guided visual inspection vs. cytology-based screening for cervical cancer in the Philippines Int J Gynecol Obstet 83 2003 141-150
35. J.L. Winkler V.D. Tsu A. Bishop et al. Confirmation of cervical neoplasia using a hand-held, lighted magnification device Int J Gynecol Obstet 81 2003 35-40
36. L. Denny L. Kuhn A. Pollack & T.C. Wright Jr Direct visual inspection for cervical cancer screening: An analysis of factors influencing test performance Cancer 94 2002 1699-1707
37. 0N. Munoz F.X. Bosch S. de Sanjose et al. International agency for research on cancer multicenter cervical cancer study group. Epidemiologic classification of human papillomavirus types associated with cervical cancer N Engl J Med 348 2003 518-527
38. E.A. Jarboe L.C. Thompson D. Heinz et al. Telomerase and human papillomavirus as diagnostic adjuncts for cervical dysplasia and carcinoma Hum Pathol 35 2004 396-402
39. M. Howard J. Sellors & J. Kaczorowski Optimizing the hybrid capture II human papillomavirus test to detect cervical intraepithelial neoplasia Obstet Gynecol 100 2002 972-980
40. E.M. Burd Human papillomavirus and cervical cancer Clin Microbiol Rev 16 2003 1-17
41. L. Denny L. Kuhn L. Risi et al. Two-stage cervical cancer screening: An alternative for resource-poor settings Am J Obstet Gynecol 18 2000 383-388
42. J.J. Baldauf M. Dreyfus M. Lehmann et al. Cervical cancer screening with cervicography and cytology Eur J Obstet Gynecol Reprod Biol 58 1995 33-39
43. M.F. Mitchell D. Schottenfeld G. Tortolero-Luna et al. Colposcopy for the diagnosis of squamous intraepithelial lesions: A meta-analysis Obstet Gynecol 91 1998 626-631
44. I. Heard J.M. Tassie V. Schmitz et al. Increased risk of cervical disease among human immunodeficiency virus-infected women with severe immunosuppression and high human papillomavirus load Obstet Gynecol 96 2000 403-409
45. T.V. Ellerbrock M.A. Chiasson T.J. Bush et al. Incidence of cervical squamous intraepithelial lesions in HIV-infected women JAMA 283 2000 1031-1037
46. D.R. Tate & R.J. Anderson Recrudescence of cervical dysplasia among women who are infected with the human immunodeficiency virus: A case-control analysis Am J Obstet Gynecol 186 2002 880-882
47. T.C. Wright Jr J. Koulos F. Schnoll et al. Cervical intraepithelial neoplasia in women infected with the human immunodeficiency virus: outcome after loop electrosurgical excision Gynecol Oncol 55 1994 253-258
48. J.F. Hines S.J. Ghim & A.B. Jenson Prospects for human papillomavirus vaccine development: Emerging HPV vaccines Curr Opin Obstet Gynecol 10 1998 15-19
49. A.D. Santin S. Bellone M. Gokden et al. Vaccination with HPV-18 E7-pulsed dendritic cells in a patient with metastatic cervical cancer N Engl J Med 346 2002 1752-1753
50. L.A. Koutsky K.A. Ault C.M. Wheeler et al. A controlled trial of a human papillomavirus type 16 vaccine N Engl J Med 347 2002 1645-1651
51. S.J. Goldie D. Grima M. Kohli et al. A comprehensive natural history model of HPV infection and cervical cancer to estimate the clinical impact of a prophylactic HPV-16/18 vaccine Int J Cancer 106 2003 896-904
52. E.C. Mauad U.A. Gomes J.L. Nogueira et al. Prevention of cervical cancer in a poor population in Brazil Fam Pract 19 2002 189-192
53. G. Walraven Prevention of cervical cancer in Africa: A daunting task? Afr J Reprod Health 7 2003 7-12
54. S.J. Russell RNA viruses as virotherapy agents Cancer Gene Ther 9 2002 961-966
55. P.M. Michelow C.A. Wright N.T. Mayet & G. Leiman Evaluation of the interim cervical cancer screening programme in the greater Johannesburg metropolitan area S Afr J Epid Infec 14 1999 36-39
56. S. Fonn B. Bloch M. Mabina et al. Prevalence of pre-cancerous lesions and cervical cancer in South Africa - a multicentre study S Afr Med J 92 2002 148-156
57. T.C. Wright Jr L. Denny L. Kuhn et al. HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer JAMA 283 2000 81-86